Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature

Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime–avibactam as a therapy for...

Full description

Bibliographic Details
Published in:Antibiotics
Main Authors: Alessandro Mancuso, Luca Pipitò, Raffaella Rubino, Salvatore Antonino Distefano, Donatella Mangione, Antonio Cascio
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Subjects:
ceftazidime–avibactam
osteomyelitis
arthritis
<i>Pseudomonas aeruginosa</i>
Online Access:https://www.mdpi.com/2079-6382/12/8/1328

Internet

https://www.mdpi.com/2079-6382/12/8/1328

Similar Items